Rocket Pharmaceuticals: Fourth Quarter Financial Results Overview

Rocket Pharmaceuticals Reports Fourth Quarter Financial Results

Rocket Pharmaceuticals Inc., headquartered in Cranbury, New Jersey, announced on Thursday that it recorded a net loss of $42.5 million for the fourth quarter.

This translates to a loss of 38 cents per share for the period.

Despite the loss, the company's performance was better than anticipated by analysts. According to Zacks Investment Research, six analysts had forecasted an average loss of 42 cents per share.

Looking at the full year, Rocket Pharmaceuticals reported a total net loss of $223.1 million, or $2.01 per share.

Financial data for this article was provided by Zacks Investment Research and compiled by Automated Insights.